Company: NDRA
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001654954-25-003612
Chunk: 882

Company: ENDRA Life Sciences Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 7A
Chunk 882
---
ally constitute and appoint each of Alexander Tokman and Richard Jacroux our true and lawful attorney, with full power to him to sign for us and in our names in the capacities indicated below, any amendments to this Annual Report on Form 10-K, and generally to do all things in our names and on our behalf in such capacities to enable ENDRA Life Sciences Inc. to comply with the provisions of the Securities Exchange Act of 1934, as amended, and all the requirements of the Securities Exchange Commission.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant and in the capacities and on the dates indicated.

Signatures Title Date     /s/ Alexander Tokman Acting Chief Executive Officer and Chairman of the Board of Directors (Principal Executive Officer) March 31, 2025Alexander Tokman         /s/ Richard Jacroux Chief Financial Officer (Principal Financial and Accounting Officer) March 31, 2025Richard Jacroux         /s/ Louis J. Basenese Director March 31 2025Louis J. Basenese         /s/ Anthony DiGiandomenico Director March 31, 2025Anthony DiGiandomenico         /s/ Michael Harsh Director March 31, 2025Michael Harsh    

 68